Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0045449
|
regulation of transcription |
MYT1,GATA2,BMI1,ZBTB10,IGF1,HIPK2,ATN1,THRB,PLAG1,NFE2L2,ZNF778,FIZ1,PAX3,HOXC6,RPS6KA5,SUV420H1,FOXO1,SETD1B,PHB,APBB2,SP1,SETD7,TP53,MLL2,TERF2IP,AFF4,TIAL1,FOXP4,MIER3,SP3,NME2,SP4,ID4,MBTD1,LITAF,IL10,ZNF800, |
3.86E-7 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
PAX3,HOXC6,FOXO1,GATA2,IGF1,SP1,TP53,HIPK2,FOXP4,TIAL1,ATN1,SP4,THRB,ID4,LITAF, |
1.23E-4 |
GO:0051252
|
regulation of RNA metabolic process |
MYT1,GATA2,IGF1,HIPK2,ATN1,THRB,NFE2L2,ZNF778,PAX3,HOXC6,FOXO1,RPS6KA5,SERBP1,SETD7,SP1,TP53,MLL2,FOXP4,TIAL1,SP3,SP4,NME2,ID4,LITAF,IL10, |
1.56E-4 |
GO:0006350
|
transcription |
MYT1,GATA2,BMI1,ZBTB10,HIPK2,THRB,PLAG1,NFE2L2,ZNF778,PAX3,FIZ1,HOXC6,FOXO1,SUV420H1,SETD1B,SETD7,SP1,TP53,MLL2,AFF4,FOXP4,SP3,MIER3,SP4,NME2,LITAF,ZNF800, |
2.29E-4 |
GO:0042127
|
regulation of cell proliferation |
PAX3,FOXO1,BMI1,EGFR,PHB,APC,IGF1,TP53,HIPK2,CUL1,NME2,LIFR,ID4,PDS5B,IL10, |
2.81E-4 |
|
GO:0006355
|
regulation of transcription, DNA-dependent |
ZNF778,MYT1,PAX3,HOXC6,GATA2,FOXO1,RPS6KA5,IGF1,SETD7,SP1,TP53,MLL2,HIPK2,FOXP4,TIAL1,ATN1,SP3,SP4,NME2,ID4,THRB,LITAF,IL10,NFE2L2, |
3.03E-4 |
GO:0051173
|
positive regulation of nitrogen compound metabolic process |
PAX3,FOXO1,GATA2,ADORA2B,EGFR,ABCA1,IGF1,SP1,TP53,HIPK2,THRB,NFE2L2,IL10, |
5.32E-4 |
GO:0051276
|
chromosome organization |
SUV420H1,RPS6KA5,BMI1,PHB,SETD1B,APC,PDS5B,SETD7,TP53,TERF2IP,MLL2, |
7.44E-4 |
GO:0031328
|
positive regulation of cellular biosynthetic process |
PAX3,FOXO1,GATA2,ADORA2B,EGFR,ABCA1,IGF1,SP1,TP53,HIPK2,THRB,NFE2L2,IL10, |
9.17E-4 |
GO:0009891
|
positive regulation of biosynthetic process |
PAX3,FOXO1,GATA2,ADORA2B,EGFR,ABCA1,IGF1,SP1,TP53,HIPK2,THRB,NFE2L2,IL10, |
1.04E-2 |
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
PAX3,HIPK2,GATA2,FOXO1,ABCA1,ADORA2B,THRB,IGF1,NFE2L2,IL10,SP1,TP53, |
1.44E-2 |
GO:0043066
|
negative regulation of apoptosis |
HIPK2,FOXO1,EGFR,NME2,APBB2,APC,IGF1,IL10,TP53, |
1.45E-2 |
GO:0043069
|
negative regulation of programmed cell death |
HIPK2,FOXO1,EGFR,NME2,APBB2,APC,IGF1,IL10,TP53, |
1.58E-2 |
GO:0060548
|
negative regulation of cell death |
HIPK2,FOXO1,EGFR,NME2,APBB2,APC,IGF1,IL10,TP53, |
1.61E-2 |
GO:0045893
|
positive regulation of transcription, DNA-dependent |
PAX3,HIPK2,GATA2,FOXO1,THRB,IGF1,NFE2L2,IL10,SP1,TP53, |
2.53E-2 |
GO:0051254
|
positive regulation of RNA metabolic process |
PAX3,HIPK2,GATA2,FOXO1,THRB,IGF1,NFE2L2,IL10,SP1,TP53, |
2.68E-2 |
GO:0042981
|
regulation of apoptosis |
ECT2,FOXO1,EGFR,PHB,APBB2,APC,IGF1,TP53,HIPK2,CUL1,TIAL1,NME2,IL10, |
3.52E-2 |
GO:0043067
|
regulation of programmed cell death |
ECT2,FOXO1,EGFR,PHB,APBB2,APC,IGF1,TP53,HIPK2,CUL1,TIAL1,NME2,IL10, |
3.81E-2 |
GO:0010941
|
regulation of cell death |
ECT2,FOXO1,EGFR,PHB,APBB2,APC,IGF1,TP53,HIPK2,CUL1,TIAL1,NME2,IL10, |
3.93E-2 |
GO:0051172
|
negative regulation of nitrogen compound metabolic process |
PAX3,HIPK2,FOXP4,ATN1,PHB,ID4,THRB,IL10,TP53,TERF2IP, |
4.43E-2 |
GO:0001503
|
ossification |
SP3,EGFR,IGF1,SP1,MMP13, |
5.43E-2 |
GO:0016568
|
chromatin modification |
SUV420H1,RPS6KA5,BMI1,PHB,SETD1B,SETD7,MLL2, |
6.71E-2 |
GO:0060348
|
bone development |
SP3,EGFR,IGF1,SP1,MMP13, |
6.88E-2 |
GO:0045941
|
positive regulation of transcription |
PAX3,HIPK2,GATA2,FOXO1,THRB,IGF1,NFE2L2,IL10,SP1,TP53, |
7.54E-2 |
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter |
PAX3,HIPK2,GATA2,FOXO1,THRB,IGF1,SP1,TP53, |
7.67E-2 |
GO:0010628
|
positive regulation of gene expression |
PAX3,HIPK2,GATA2,FOXO1,THRB,IGF1,NFE2L2,IL10,SP1,TP53, |
9.08E-2 |
GO:0001892
|
embryonic placenta development |
GATA2,SP3,SP1, |
9.40E-2 |
GO:0050678
|
regulation of epithelial cell proliferation |
EGFR,NME2,APC,IGF1, |
9.43E-2 |
GO:0048732
|
gland development |
ATP7B,GATA2,EGFR,NME2,IGF1, |
9.49E-2 |
|
|
|
|
|
|